GlassScriptPhysician profile
Nash H Naam
NPI 1346234754
$928.51
in general payments reported to CMS, 2019-2025
10 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.95 · 2020: $40.94 · 2021: $250 · 2022: $135 · 2023: $60.80 · 2024: $209 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $229.35 | 2021-2022 | |
| Amgen INC. | $227.21 | 2024-2025 | Krystexxa |
| Endo Pharmaceuticals INC. | $135.78 | 2019-2023 | Xiaflex |
| Acumed LLC | $117.40 | 2024 | Acumed, Inframe Implant |
| Elite Orthopedics, LLC | $84.92 | 2021-2023 | |
| Stryker Corporation | $40.87 | 2021 | |
| Axogen | $36.18 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $22.15 | 2024 | Exparel |
| Bioventus LLC | $20.58 | 2024 | Exogen Ultrasound Bone Healing System |
| Baudax Bio INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nash Naam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.